logo


Lam Research Corporation Announces Financial Results for the Quarter Ended March 29, 2009
Wednesday, April 22, 2009 5:15 PM


(Source: Business Wire)trackingLam Research Corporation (NASDAQ:LRCX) highlights for the March 2009 quarter were:

  (in thousands, except per share data and percentages)                                                                                                 ?  Revenue:           $  174,412                                                                                                                                            U.S. GAAP                            Ongoing         ?  Operating Margin:     -111.9                        %      -47.1    %                                                                              ?  Net Loss:          $  (198,359                      )   $  (89,771  )                                                                              ?  Diluted EPS:       $  (1.58                         )   $  (0.71    )    -------------------------------------------------------------------------------  

Lam Research Corporation today announced financial results for the quarter ended March 29, 2009. Revenue for the period was $174.4million, gross margin was $36.5million and net loss was $(198.4) million, or $(1.58) per diluted share, compared to revenue of $283.4million, gross margin of $101.4million and net loss of $(24.2)million, or $(0.19) per diluted share, for the December2008 quarter. Shipments for the March 2009 quarter were $159million compared to $226million during the December2008 quarter.

As a result of a combination of factors, including the current economic environment, a sustained decline in the Company's market valuation and a decline in the Company's operating results, the Company has concluded that the fair value of its Clean Product Group has been reduced below its carrying value. As a result, the Company has recorded a non-cash goodwill impairment charge of approximately $89.1 million during the March 2009 quarter. The goodwill impairment charge is based on the Company's current best estimate. If there is a change to this estimate, it will be reflected in the March 2009 quarter financial statements included in the Company's quarterly report on Form 10-Q for the quarter ended March 29, 2009, which is anticipated to be filed on or before May 8, 2009.

The Company's ongoing results for the March 2009 quarter exclude certain costs for previously announced restructuring activities and asset impairments, the goodwill impairment charge noted above, a net tax expense for a change in state tax law, a net tax expense and an exchange rate gain associated with the Company's accelerated tax planning strategy, an investment impairment, and interest on the tax liability associated with the outcome of the Company's previously disclosed voluntary internal stock option review. The Company's ongoing results for the December2008 quarter excluded certain costs for restructuring activities and asset impairments, a net tax benefit related to the renewal of the research and development tax credit, net tax expense on resolution of certain tax items, one-time costs associated with the restructuring of an employee benefit plan, a net tax benefit and an exchange rate loss associated with the Company's accelerated tax planning strategy, and interest on the tax liability associated with the outcome of the Company's previously disclosed voluntary internal stock option review. Management uses the presentation of ongoing gross margin, ongoing operating expenses, ongoing operating loss, ongoing net loss, and ongoing net loss per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of ongoing results is useful to investors for analyzing ongoing business trends and comparing performance to prior periods, and enhances the investor's ability to view the Company's results from management's perspective. A table presenting a reconciliation of ongoing results to results under U.S. GAAP is included at the end of this press release and on the Company's web site.

Ongoing net loss was $(89.8) million, or $(0.71) per diluted share in the March 2009 quarter compared to ongoing net loss of $(11.7)million, or $(0.09) per diluted share, for the December2008 quarter. Ongoing gross margin for the March 2009 quarter was $46.7million or 26.8%, compared to ongoing gross margin of $109.1million, or 38.5%, for the December2008 quarter. The sequential decline in gross margin was primarily due to lower manufacturing and field utilization levels resulting from reduced business activity as well as product mix. Ongoing operating expenses for the March 2009 quarter increased to $128.9million compared with the December2008 quarter of $126.5million. This increase was driven by additional accounts receivables reserves for specific distressed customers, partially offset by a reduction in employee expenses as a result of restructuring and other cost-savings activities.

The geographic distribution of shipments and revenue during the March 2009 quarter is shown in the following table:

  Region          Shipments   Revenue   North America   16%         15%       Europe          17%         14%       Japan           27%         24%       Korea           17%         19%       Taiwan          15%         20%       Asia Pacific    8%          8%         -------------------------------------------------------------------------------  

Cash and cash equivalents, short-term investments and restricted cash and investments balances were $806.4million at the end of the March 2009 quarter, compared to $1.1billion at the end of the December2008 quarter. The Company paid the outstanding principal balance of $237.5 million of its long-term debt during the March 2009 quarter. Cash flows from operating activities were approximately $(24.2) million during the March 2009 quarter. Deferred revenue and deferred profit balances at the end of the March 2009 quarter were $43.7million and $36.1million, respectively. Our deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The anticipated future revenue from shipments to Japanese customers was approximately $7.5million as of March 29, 2009.

"We are developing next-generation technology solutions alongside our customers and are continuing to win new application tool selection decisions in both etch and clean at the leading-edge technology nodes. We are fortunate to have a strong balance sheet with sufficient cash to: continue making investments in key R&D programs, place next-generation tools at customer sites for joint development projects and evaluations, and deploy inventories to meet short-term shipment requirements as well as respond to any future increases in demand," said Steve Newberry, Lam's president and chief executive officer. "Our focus remains on investing in strategic opportunities while aggressively managing the cost structure and cash expenditures of the Company. This will enhance our ability to meet the expectations and needs of our customers and strengthen our market position for the next upturn," Newberry concluded.

Statements made in this press release which are not statements of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate, but are not limited, to our estimate of the goodwill impairment charge, the anticipated revenue from shipments to Japanese customers, the potential uses of our cash and other assets, and our ability to develop next generation technology solutions, win new application tool selection decisions in both etch and clean, continue to be able to invest in research and development, place next-generation tools at customer sites, be successful in deploying our inventory to meet demand, focus on and invest in strategic opportunities, be successful in managing our cost structure and cash expenditures, meet the expectations and needs of our customers, and strengthen our market position. Some factors that may affect these forward-looking statements include: difficult business conditions in the semiconductor industry and the overall economy and the efficacy of our plans for reacting to those conditions, factors that tend to make our quarterly results more volatile (such as exchange rate fluctuations), changing customer demands, the actions of our competitors, and the challenges presented by the development and marketing of our new products and the integration of acquired businesses and technologies into our existing business. These forward-looking statements are based on current expectations and are subject to uncertainties and changes in condition, significance, value and effect as well as other risks detailed in documents filed with the Securities and Exchange Commission, including specifically the report on Form 10-K for the year ended June29, 2008, and Form 10-Q for the quarters ended September28, 2008 and December 28, 2008, which could cause actual results to vary from expectations. The Company undertakes no obligation to update the information or statements made in this press release.

Lam Research Corporation is a major provider of wafer fabrication equipment and services to the world's semiconductor industry. Lam's common stock trades on The NASDAQ Global Select MarketSM under the symbol LRCX. Lam is a NASDAQ-100® company. For more information, visit www.lamresearch.com.

Consolidated Financial Tables Follow

  LAM RESEARCH CORPORATION                                                                                                                       CONSOLIDATED STATEMENTS OF OPERATIONS                                                                                                          (in thousands, except per share data and percentages)                                                                                          (unaudited)                                                                                                                                                                                                                                                                                                                                              Three Months Ended                               Nine Months Ended                                                                             March 29,        December 28,    March 30,       March 29,        March 30,                                                                       2009             2008            2008            2009             2008           Total revenue                                              $  174,412       $  283,409      $  613,810      $  898,182       $  1,908,751      Cost of goods sold                                            127,680          174,329         320,201         556,212          963,594        Cost of goods sold - 409A expense                             -                -               6,401           -                6,401          Cost of goods sold - restructuring and asset impairments      10,217           7,728           -               20,993           -              Total cost of goods sold                                      137,897          182,057         326,602         577,205          969,995        Gross margin                                                  36,515           101,352         287,208         320,977          938,756        Gross margin as a percent of revenue                          20.9      %      35.8     %      46.8     %      35.7      %      49.2       %   Research and development                                      70,434           68,781          80,576          220,778          237,107        Selling, general and administrative                           58,515           59,842          74,491          185,813          210,288        Goodwill impairment                                           89,076           -               -               89,076           -              Restructuring and asset impairments                           13,028           10,121          -               39,117           -              409A expense                                                  646              -               43,784          2,250            43,784         In-process research and development                           -                -               2,074           -                2,074          Total operating expenses                                      231,699          138,744         200,925         537,034          493,253        Operating income (loss)                                       (195,184  )      (37,392  )      86,283          (216,057  )      445,503        Operating margin as a percent of revenue                      -111.9    %      -13.2    %      14.1     %      -24.1     %      23.3       %   Other income (expense), net                                   13,497           (7,233   )      49,605          15,281           57,201         Income (loss) before income taxes                             (181,687  )      (44,625  )      135,888         (200,776  )      502,704        Income tax expense (benefit)                                  16,672           (20,453  )      32,364          12,882           135,533        Net income (loss)                                          $  (198,359  )   $  (24,172  )   $  103,524      $  (213,658  )   $  367,171        Net income (loss) per share:                                                                                                                   Basic net income (loss) per share                          $  (1.58     )   $  (0.19    )   $  0.83         $  (1.70     )   $  2.95           Diluted net income (loss) per share                        $  (1.58     )   $  (0.19    )   $  0.82         $  (1.70     )   $  2.90           Number of shares used in per share calculations:                                                                                               Basic                                                         125,566          125,084         124,768         125,368          124,509        Diluted                                                       125,566          125,084         126,549         125,368          126,531         -------------------------------------------------------------------------------  
  LAM RESEARCH CORPORATION                                                                    CONDENSED CONSOLIDATED BALANCE SHEETS                                                       (in thousands)                                                                                                                                                                                                                        March 29,      December 28,   June 29,                                                      2009           2008           2008                                                          (unaudited)    (unaudited)    (1)             ASSETS                                                                                      Cash and cash equivalents                     $  374,648     $  652,913     $  732,537      Short-term investments                           248,500        297,399        326,199      Accounts receivable, net                         196,842        290,565        412,356      Inventories                                      260,667        269,959        282,218      Deferred income taxes                            90,541         93,002         96,748       Other current assets                             82,273         56,648         67,649       Total current assets                             1,253,471      1,660,486      1,917,707    Property and equipment, net                      225,864        233,250        235,735      Restricted cash and investments                  183,277        168,405        146,072      Deferred income taxes                            15,281         25,836         19,793       Goodwill and intangible assets                   268,249        371,987        403,187      Other assets                                     87,340         78,457         84,261       Total assets                                  $  2,033,482   $  2,538,421   $  2,806,755                                                                                                LIABILITIES AND STOCKHOLDERS' EQUITY                                                        Current liabilities                           $  369,998     $  446,412     $  637,679                                                                                                  Long-term debt and capital leases             $  39,943      $  257,135     $  276,121      Income taxes payable                             99,807         92,382         85,611       Other long-term liabilities                      20,476         21,300         23,400       Minority interests                               -              -              5,347        Stockholders' equity                             1,503,258      1,721,192      1,778,597    Total liabilities and stockholders' equity    $  2,033,482   $  2,538,421   $  2,806,755                                                                                                1 Derived from audited financial statements                                                  -------------------------------------------------------------------------------  
  LAM RESEARCH CORPORATION                                                                                                                                                                  CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS                                                                                                                                           (in thousands)                                                                                                                                                                            (unaudited)                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Three Months Ended                                Nine Months Ended                                                                                                                       March 29,        December 28,    March 30,        March 29,        March 30,                                                                                                                 2009             2008            2008             2009             2008                                                                                                                                                                                                    CASH FLOWS FROM OPERATING ACTIVITIES:                                                                                                                                                     Net income (loss)                                                                                     $  (198,359  )   $  (24,172  )   $  103,524       $  (213,658  )   $  367,171       Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:                                                                                       Depreciation and amortization                                                                            19,650           17,177          12,914           54,723           35,477        Deferred income taxes                                                                                    12,929           10,110          (11,995   )      10,632           (22,009   )   Equity-based compensation expense                                                                        10,227           14,049          10,272           39,684           30,887        Income tax benefit on equity-based compensation plans                                                    (11,115   )      (7,045   )      (520      )      (13,121   )      56,657        Excess tax benefit on equity-based compensation plans                                                    7,027            3,752           401              6,510            (37,238   )   Net gain on settlement of call option                                                                    -                -               (40,864   )      -                (33,694   )   Goodwill impairment                                                                                      89,076           -               -                89,076           -             Restructuring and asset impairments                                                                      23,245           17,849          -                60,110           -             Other, net                                                                                               953              3,200           (7,013    )      6,818            (2,867    )   Changes in operating asset accounts                                                                      22,215           (73,909  )      79,266           (60,783   )      (4,512    )   Net cash provided by (used for) operating activities                                                     (24,152   )      (38,989  )      145,985          (20,009   )      389,872                                                                                                                                                                                                 CASH FLOWS FROM INVESTING ACTIVITIES:                                                                                                                                                     Capital expenditures and intangible assets                                                               (10,866   )      (12,417  )      (19,291   )      (38,434   )      (57,852   )   Acquisitions of businesses, net of cash acquired                                                         (11,706   )      (8,763   )      (473,408  )      (22,896   )      (475,656  )   Net sales (purchases) of available-for-sale securities                                                   33,961           39,767          83,201           80,708           51,316        Purchase of call option                                                                                  -                -               (3,227    )      -                (13,506   )   Proceeds from settlement of call option                                                                  -                -               46,962                            46,962        Purchases of other investments                                                                           -                -               -                -                (4,560    )   Other                                                                                                    (8,375    )      (2,000   )      -                (10,375   )      -             Transfer of restricted cash and investments                                                              558              (32,178  )      (688      )      (47,748   )      (1,762    )   Net cash provided by (used for) investing activities                                                     3,572            (15,591  )      (366,451  )      (38,745   )      (455,058  )                                                                                                                                                                                             CASH FLOWS FROM FINANCING ACTIVITIES:                                                                                                                                                     Principal payments on long-term debt and capital lease obligations                                       (239,703  )      (13,060  )      (250,114  )      (255,136  )      (250,214  )   Net proceeds from issuance of long-term debt                                                             -                515             250,000          625              250,000       Excess tax benefit on equity-based compensation plans                                                    (7,027    )      (3,752   )      (401      )      (6,510    )      37,238        Treasury stock purchases                                                                                 (546      )      (24,448  )      (737      )      (27,749   )      (10,962   )   Reissuances of treasury stock                                                                            5,942            -               -                13,526           7,301         Proceeds from issuance of common stock                                                                   1,283            1,294           -                5,727            10,106        Net cash provided by (used for) financing activities                                                     (240,051  )      (39,451  )      (1,252    )      (269,517  )      43,469        Effect of exchange rate changes on cash                                                                  (17,634   )      1,512           (1,984    )      (29,618   )      103           Net decrease in cash and cash equivalents                                                                (278,265  )      (92,519  )      (223,702  )      (357,889  )      (21,614   )   Cash and cash equivalents at beginning of period                                                         652,913          745,432         776,055          732,537          573,967       Cash and cash equivalents at end of period                                                            $  374,648       $  652,913      $  552,353       $  374,648       $  552,353        -------------------------------------------------------------------------------  
  Reconciliation of U.S. GAAP Net Loss to Ongoing Net Loss                                                                                              (in thousands, except per share data)                                                                                                                                                                                                                                                                                                                                                                                   Three Months Ended   Three Months Ended                                                                                                               March 29,            December 28,                                                                                                                     2009                 2008                 U.S. GAAP net loss                                                                                          $  (198,359  )       $  (24,172  )        Pre-tax non-ongoing items:                                                                                                                            Goodwill impairment - operating expenses                                                                       89,076               -                 Restructuring and asset impairments - cost of goods sold                                                       10,217               7,728             Restructuring and asset impairments - operating expenses                                                       13,028               10,121            Restructuring of employee benefit plan - operating expenses                                                    -                    1,300             Voluntary internal stock option review - operating expenses                                                    646                  843               Impairment of investment - other income (expense), net                                                         1,543                -                 Exchange rate (gain) loss associated with accelerated tax planning strategy - other income (expense), net      (6,674    )          7,569             Net tax benefit on non-ongoing items                                                                           (5,506    )          (7,375   )        Net tax benefit on renewal of R&D tax credit                                                                   -                    (5,751   )        Net tax expense on resolution of certain tax matters                                                           -                    1,396             Net tax expense on change in state tax law                                                                     5,244                -                 Net tax expense (benefit) on accelerated tax planning strategy                                                 1,014                (3,407   )        Ongoing net loss                                                                                            $  (89,771   )       $  (11,748  )        Ongoing net loss per diluted share                                                                          $  (0.71     )       $  (0.09    )        Number of shares used for diluted per share calculation                                                        125,566              125,084                                                                                                                                                                                                                                                                                                                       Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Loss to Ongoing Gross Margin, Operating Expenses and Operating Loss        (in thousands, except percentages)                                                                                                                                                                                                                                                                                                                                                                                      Three Months Ended   Three Months Ended                                                                                                               March 29,            December 28,                                                                                                                     2009                 2008                 U.S. GAAP gross margin                                                                                      $  36,515            $  101,352           Pre-tax non-ongoing items:                                                                                                                            Restructuring and asset impairments - cost of goods sold                                                       10,217               7,728             Ongoing gross margin                                                                                        $  46,732            $  109,080           U.S. GAAP gross margin as a percent of revenue                                                                 20.9%                35.8%             Ongoing gross margin as a percent of revenue                                                                   26.8%                38.5%             U.S. GAAP operating expenses                                                                                $  231,699           $  138,744           Pre-tax non-ongoing items:                                                                                                                            Goodwill impairment - operating expenses                                                                       (89,076   )          -                 Restructuring and asset impairments - operating expenses                                                       (13,028   )          (10,121  )        Restructuring of employee benefit plan - operating expenses                                                    -                    (1,300   )        Voluntary internal stock option review - operating expenses                                                    (646      )          (843     )        Ongoing operating expenses                                                                                  $  128,949           $  126,480           Ongoing operating loss                                                                                      $  (82,217   )       $  (17,400  )        Ongoing operating loss as a percent of revenue                                                                 -47.1     %          -6.1     %         -------------------------------------------------------------------------------  

A service of YellowBrix, Inc.



(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Advertisement
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia